See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
USANA Health Sciences, Inc. (USNA) - free report >>
Appian Corporation (APPN) - free report >>
NRx Pharmaceuticals, Inc. (NRXP) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
USANA Health Sciences, Inc. (USNA) - free report >>
Appian Corporation (APPN) - free report >>
NRx Pharmaceuticals, Inc. (NRXP) - free report >>
Image: Bigstock
New Strong Buy Stocks for December 30th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
CoreCard Corporation (CCRD - Free Report) : This technology solutions and processing services company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.
CoreCard Corporation Price and Consensus
CoreCard Corporation price-consensus-chart | CoreCard Corporation Quote
Appian Corporation (APPN - Free Report) : This software company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Appian Corporation Price and Consensus
Appian Corporation price-consensus-chart | Appian Corporation Quote
USANA Health Sciences, Inc. (USNA - Free Report) : This nutritional, personal care, and skincare products company has seen the Zacks Consensus Estimate for its next year earnings increasing 12.8% over the last 60 days.
USANA Health Sciences, Inc. Price and Consensus
USANA Health Sciences, Inc. price-consensus-chart | USANA Health Sciences, Inc. Quote
Entrada Therapeutics, Inc. (TRDA - Free Report) : This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.
Entrada Therapeutics, Inc. Price and Consensus
Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote
NRx Pharmaceuticals, Inc. (NRXP - Free Report) : This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
NRx Pharmaceuticals, Inc. Price and Consensus
NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.